56
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T74427 | Paridiprubart | ||
Paridiprubart (NI-0101), a humanized monoclonal antibody targeting TLR4, offers promising research avenues for rheumatoid arthritis [1]. | |||
T82461 | Epacmarstobart | GS-0189,FSI-189 | |
Epacmarstobart (FSI-189; GS-0189) is a chimeric humanized IgG1κ antibody designed to target the mouse Signal Regulatory Protein Alpha (SIRPA). | |||
T82474 | Empasiprubart | ARGX-117 | |
Empasiprubart (ARGX-117) is a humanized inhibitory monoclonal antibody targeting complement C2. It inhibits the formation of C3 proconvertase, obstructing classical and lectin pathway activation by binding to the Sushi-2... | |||
T82268 | Gotistobart | BNT 316,ONC-392 | |
Gotistobart (ONC-392) is a humanized anti-CTLA-4 antibody that enhances immunotherapy by selectively depleting regulatory T cells (Treg) within the tumor microenvironment [1]. | |||
T82946 | Atisnolerbart | ||
Atisnolerbart, a human IgG4 antibody, specifically targets BETVIA, which is identified as the major birch pollen allergen, Bet v 1-A. | |||
T82371 | Freneslerbart | ||
Freneslerbart, an IgG4κ antibody, specifically targets Felcat allergen 1, an allergenic protein [1]. | |||
T81610 | Oloctinebart | ||
Oloctinebart, a humanized immunoglobulin G4-kappa (IgG4-κ) monoclonal antibody targeting LGALS3, is utilized to decrease the formation of amyloid beta oligomers [1]. | |||
T80918 | Tuparstobart | Incagn-02385 | |
Tuparstobart (Incagn-02385) is an IgG1κ monoclonal antibody that targets the immune checkpoint receptor protein LAG-3, which is predominantly expressed on activated T cells, NK cells, B cells, and plasmacytoid dendritic ... | |||
T80564 | Vamikibart | ||
Vamikibart is a chimeric, humanized IgG2κ antibody that targets IL6 [1]. | |||
T81260 | Rolistobart | ||
Rolistobart is a humanized IgG4-κ monoclonal antibody targeting LILRB4/CD85k. It functions as an immunostimulant and antineoplastic agent [1]. | |||
T81805 | Mevonlerbart | ||
Mevlonerbart, an IgG4κ antibody, specifically targets human Felcat allergen 1, an allergen protein. | |||
T78659 | Crexavibart | BMS-986413,C-144-LS | SARS-CoV |
Crexavibart (BMS-986413; C-144-LS), an IgG1 λ2 antibody, specifically targets the receptor-binding domain of the SARS-CoV-2 spike (S) glycoprotein [1]. | |||
T81022 | Tegoprubart | ||
Tegoprubart is a monoclonal antibody targeting CD40 ligand (CD40L), which plays a critical role in costimulation. By inhibiting CD40L, it diminishes both cellular and antibody-mediated immune responses, fostering a more ... | |||
T80572 | Exlinkibart | LVGN-6051 | |
Exlinkibart (LVGN-6051) is a humanized IgG1κ antibody that selectively targets TNFRSF9, utilizing complementarity-determining region (CDR) grafting technology for its humanization. | |||
T81124 | Sovipostobart | ||
Sovipostobart, an immunoglobulin G1-kappa monoclonal antibody targeting CTLA-4 in Homo sapiens, features a cleavable prodomain. This compound serves as both an immunostimulant and antineoplastic [1]. | |||
T80571 | Eurestobart | Phosphatase | |
Eurestobart is a humanized IgG1κ (IgG1 kappa) monoclonal antibody that specifically targets the enzyme ectonucleoside triphosphate diphosphohydrolase (ENTPDase). | |||
T82077 | Iluzanebart | ||
Iluzanebart is a human IgG1κ monoclonal antibody that selectively targets TREM2—a triggering receptor expressed on myeloid cells [1]. | |||
T80902 | Umesolerbart | ||
Umesolerbart (REGN5714) is a monoclonal antibody (mAb) specific to Bet v1 that also binds to homologous allergens in Alder, Hazel, and Hornbeam [1]. | |||
T81928 | Lipustobart | PD-1/PD-L1 | |
Lipustobart is an IgG4-kappa humanized monoclonal antibody targeting PDCD1 (programmed cell death 1, PD1, PD-1, CD279), with immunostimulant and antineoplastic activity [1]. | |||
T81925 | Lixudebart | ||
Lixudebart is a humanized IgG1-kappa monoclonal antibody that targets CLDN1 [1]. | |||
T80903 | Ulviprubart | ABC-008 | |
Ulviprubart, an anti-KLRG1 monoclonal antibody (mAb), is utilized in various disease research [1]. | |||
T80575 | Simaravibart | MAD-0004J08 | SARS-CoV |
Simaravibart (MAD-0004J08), an IgG1κ monoclonal antibody, specifically targets the receptor-binding domain of the SARS-CoV-2 spike (S) glycoprotein [1]. | |||
T80560 | Tulisokibart | PRA-023,PRA023 | |
Tulisokibart (PRA023) is a humanized IgG1-κ monoclonal antibody that targets TNFSF15/TL1A, with potential applications in researching various inflammatory and fibrotic diseases, including Crohn's Disease (CD) [1] [2]. | |||
T80959 | Trabikibart | CSL311 | |
Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, specifically binds to the cytokine-binding epitope of the human βc receptor with picomolar affinity. It potently inhibits the collective impact of IL-... | |||
T80577 | Varokibart | ||
Varokibart (TEV-53275) is a human IgG4λ antibody that targets interleukin-5 (IL-5) [1]. | |||
T80868 | Verzistobart | ||
Verzistobart, an IgG1κ antibody, specifically targets the hepatitis A virus cellular receptor, HAVCR2. | |||
T74424 | Masavibart | ||
Masavibart (ZRC3308-A7), an IgG1 type anti-SARS-CoV-2 monoclonal antibody, demonstrates strong binding affinity for a distinct non-competing epitope located on the receptor-binding domain (RBD) of the SARS-CoV-2 spike pr... | |||
T74425 | Nepuvibart | ||
Nepuvibart (ZRC3308-B10), an IgG1 type anti-SARS-CoV-2 monoclonal antibody, exhibits strong binding affinity to a distinct non-competing epitope on the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. When ... | |||
T82615 | Dalnicastobart | LVGN-7409 | |
Dalnicastobart (LVGN-7409) is a human IgG1κ monoclonal antibody that specifically targets CD40, also known as TNFRSF5 [1]. | |||
T82465 | Enlonstobart | ||
Enlonstobart is a humanized IgG4-κ monoclonal antibody targeting PDCD1, functioning as both an immunostimulant and antineoplastic agent [1]. | |||
T82409 | Fepixnebart | ||
Fepixnebart is a humanized IgG4κ antibody that targets TGF-alpha (TGFA). | |||
T80576 | Picankibart | ||
Picankibart is a mouse-origin monoclonal antibody (IgG1κ) that targets interleukin 23A (IL23A) [1]. | |||
T80970 | Tobevibart | HBV | |
Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1]. | |||
T80566 | Temtokibart | ||
Temtokibart is a humanized IgG1 λ2 antibody that specifically targets IL22RA1, and is expressed by cells that are deficient in the glutamine synthetase gene. | |||
T81314 | Rademikibart | CBP-201 | |
Rademikibart (CBP-201) is a human monoclonal antibody selective for IL-4Rα, exhibiting strong affinity with a KD of 20.7 pM for human IL-4Rα epitopes, without cross-reactivity to IL-4Rα from other species. It effectively... | |||
T81410 | Prafnosbart | DS-6016A | |
Prafnosbart (DS-6016A) is a humanized IgG1-kappa monoclonal antibody targeting ACVR1 (activin A receptor type 1, ACVRLK2, ALK2, ACVR1A, SKR1), utilized in research on bone metabolism disorders [1]. | |||
T81538 | Patecibart | Endothelin Receptor | |
Patecibart is a humanized immunoglobulin G4-kappa monoclonal antibody that functions as an antagonist to the endothelin receptor A (EDNRA). | |||
T81297 | Renvistobart | ||
Renvistobart is a monoclonal antibody belonging to the immunoglobulin G1-κ class, targeting the human T cell immunoreceptor with Ig and ITIM domains (TIGIT, also known as VSIG9 or VSTM3) [1]. | |||
T80578 | Evunzekibart | ATOR-1017 | |
Evunzekibart (ATOR-1017) is an Fc-γ receptor-dependent 4-1BB agonist and an IgG4 isotype antibody. It can function as a monotherapy or synergize with anti-PD1 therapies to promote anti-tumor effects. | |||
T80569 | Benmelstobart | PD-1/PD-L1 | |
Benmelstobart, an IgG1κ antibody, targets PD-L1/CD274 and is of murine origin [1]. | |||
T80570 | Dazukibart | IFNAR | |
Dazukibart is a humanized IgG1κ monoclonal antibody of murine origin, specifically targeting interferon beta 1 (IFNB1) [1]. | |||
T25138 | Barthrin | ||
Barthrin is used as an Experimental Pesticide. | |||
T74426 | Ogalvibart | ||
Ogalvibart (C-135-LS), a humanized anti-SARS-CoV-2 IgG1 type monoclonal antibody, specifically targets and binds to the spike (S) glycoprotein receptor-binding domain (RBD) of the SARS-CoV-2 virus. When combined with C14... | |||
T82820 | Bremzalerbart | ||
Bremzalerbart is a human IgG4 antibody that targets BETVIA, which is the primary allergen Bet v 1-A [1] in birch pollen. | |||
T82994 | Anzurstobart | BMS-986351,CC-95251 | |
Anzurstobart (CC-95251; BMS-986351), a fully human monoclonal anti-SIRPα antibody with high affinity, inhibits CD47-SIRPα interaction. It potentiates macrophage-mediated phagocytosis of DLBCL cell lines in co-culture ass... | |||
T82589 | Delpacibart | ||
Delpacibart is a humanized mouse IgG1κ antibody that targets TFRC, a critical membrane protein regulating intracellular iron transport [1]. | |||
T82899 | Bempikibart | ADX-914 | |
Bempikibart (ADX-914), a human anti-IL-7Rα antibody, has potential applications in anti-inflammatory research [1]. | |||
T82440 | Erzotabart | CD38 | |
Erzotabart, an IgG1-kappa monoclonal antibody targeting CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) in Homo sapiens, exhibits antineoplastic activity [1]. | |||
T81098 | Stapokibart | CM310 | |
Stapokibart (CM310), a humanized monoclonal antibody, selectively binds to IL-4Rα, inhibiting the cytokines IL-4 and IL-13 from interacting with their shared co-receptor subunit, IL-4Rα. This compound demonstrates cross-... | |||
T80618 | Narlumosbart | RANKL/RANK | |
Narlumosbart (JMT103) is an IgG4κ monoclonal antibody that selectively binds to the receptor activator of nuclear factor-κB ligand (RANKL)[1]. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-03500 | ARL2BP Protein, Human, Recombinant (His) | Human | E. coli |
ADP-ribosylation factor (ARF)-like proteins (ARLs) comprise a functionally distinct group of the ARF family of RAS-related GTPases. ARL2BP binds to ARL2.GTP with high affinity but does not interact with ARL2.GDP, activ... |